Cargando…

High KIF2A expression predicts unfavorable prognosis in diffuse large B cell lymphoma

Kinesin family member 2A (KIF2A), a conserved motor protein, plays a critical role in the pathogenesis and prognosis of several malignant tumors. The aim of the present study was to investigate KIF2A expression in diffuse large B cell lymphoma (DLBCL), evaluate the association between KIF2A expressi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Yaping, You, Xuefen, Liu, Hong, Xu, Mengqi, Dang, Qingxiu, Yang, Li, Huang, Jianfei, Shi, Wenyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5537331/ https://www.ncbi.nlm.nih.gov/pubmed/28616658 http://dx.doi.org/10.1007/s00277-017-3047-1

Ejemplares similares

High nuclear expression of STAT3 is associated with unfavorable prognosis in diffuse large B-cell lymphoma
por: ZL, Wu, et al.
Publicado: (2011)

MYD88 mutations identify a molecular subgroup of diffuse large B-cell lymphoma with an unfavorable prognosis
por: Vermaat, Joost S., et al.
Publicado: (2020)

High KIF18A expression correlates with unfavorable prognosis in primary hepatocellular carcinoma
por: Liao, Weijia, et al.
Publicado: (2014)

Noncoding RNAs-mediated overexpression of KIF14 is associated with tumor immune infiltration and unfavorable prognosis in lung adenocarcinoma
por: Wang, Hong, et al.
Publicado: (2022)

Increased interleukin-17A levels promote rituximab resistance by suppressing p53 expression and predict an unfavorable prognosis in patients with diffuse large B cell lymphoma
por: Zhong, Weijie, et al.
Publicado: (2018)

KIF23 is a potential biomarker of diffuse large B cell lymphoma: Analysis based on bioinformatics and immunohistochemistry
por: Gong, Yuqi, et al.
Publicado: (2022)

Promising Response to Lenalidomide-Combination Therapy in a Discordant Lymphoma Consisting of EBV-Positive Diffuse Large B-Cell Lymphoma and Angioimmunoblastic T-Cell Lymphoma: A Case Report
por: Hu, Pan, et al.
Publicado: (2021)

Increased expression of KPNA2 predicts unfavorable prognosis in ovarian cancer patients, possibly by targeting KIF4A signaling
por: Cui, Xiangrong, et al.
Publicado: (2021)

KIF2A silencing inhibits the proliferation and migration of breast cancer cells and correlates with unfavorable prognosis in breast cancer
por: Wang, Jianli, et al.
Publicado: (2014)

SEPT6_TRIM33 Gene Fusion and Mutated TP53 Pathway Associate With Unfavorable Prognosis in Patients With B-Cell Lymphomas
por: Fu, Haiying, et al.
Publicado: (2021)

Tumor Microenvironment in Diffuse Large B-Cell Lymphoma: Role and Prognosis
por: Cioroianu, Alexandra Ioana, et al.
Publicado: (2019)

Influence of Hyperglycemia on the Prognosis of Patients with Diffuse Large B-Cell Lymphoma
por: Zhou, Weiling, et al.
Publicado: (2022)

Identification of microtubule-associated biomarkers in diffuse large B-cell lymphoma and prognosis prediction
por: Wu, Wenqi, et al.
Publicado: (2023)

Increased expression of IRF8 in tumor cells inhibits the generation of Th17 cells and predicts unfavorable survival of diffuse large B cell lymphoma patients
por: Zhong, Wei-Jie, et al.
Publicado: (2017)

Multi-omics analysis reveals the association between elevated KIF18B expression and unfavorable prognosis, immune evasion, and regulatory T cell activation in nasopharyngeal carcinoma
por: Tang, Siqi, et al.
Publicado: (2023)

A 9-LncRNA Signature for Predicting Prognosis and Immune Response in Diffuse Large B-Cell Lymphoma
por: Wang, Xiaoxuan, et al.
Publicado: (2022)

Poor Prognosis of Diffuse Large B-Cell Lymphoma with Hepatitis C Infection
por: Tsai, Yu-Fen, et al.
Publicado: (2021)

Predicting Outcomes in Patients With Diffuse Large B-Cell Lymphoma Treated With Standard of Care
por: Galaznik, Aaron, et al.
Publicado: (2019)

A model to predict the prognosis of diffuse large B-cell lymphoma based on ultrasound images
por: Lu, Wenjuan, et al.
Publicado: (2023)

Vagal Nerve Activity Predicts Prognosis in Diffused Large B-Cell Lymphoma and Multiple Myeloma
por: Atar, Or, et al.
Publicado: (2023)

Corrigendum: Identification of microtube-associated biomarkers in diffuse large B-cell lymphoma and prognosis prediction
por: Wu, Wenqi, et al.
Publicado: (2023)

Mutations or copy number losses of CD58 and TP53 genes in diffuse large B cell lymphoma are independent unfavorable prognostic factors
por: Cao, Yang, et al.
Publicado: (2016)

Immunophenotypic Landscape and Prognosis-Related mRNA Signature in Diffuse Large B Cell Lymphoma
por: Jiang, Yanan, et al.
Publicado: (2022)

PB2375: PLTP REGULATES BCR SIGNALING AND TUMOR MICROENVIRONMENT IN DIFFUSE LARGE B-CELL LYMPHOMA THROUGH REPROGRAMMING OF LIPID METABOLISM ENVIRONMENT
por: Shi, Wenyu
Publicado: (2023)

The Metabolism and Immune Environment in Diffuse Large B-Cell Lymphoma
por: Wu, Jianbo, et al.
Publicado: (2023)

Deregulation of COMMD1 Is Associated with Poor Prognosis in Diffuse Large B-cell Lymphoma
por: Taskinen, Minna, et al.
Publicado: (2014)

Plasma Metabolites Forecast Occurrence and Prognosis for Patients With Diffuse Large B-Cell Lymphoma
por: Fei, Fei, et al.
Publicado: (2022)

Tumor-associated macrophages predict prognosis in diffuse large B-cell lymphoma and correlation with peripheral absolute monocyte count
por: Li, Yan-Li, et al.
Publicado: (2019)

Coexpression of CD5 and CD43 predicts worse prognosis in diffuse large B‐cell lymphoma
por: Ma, Xiao‐bo, et al.
Publicado: (2018)

Predictive value of Dmax and %ΔSUVmax of (18)F-FDG PET/CT for the prognosis of patients with diffuse large B-cell lymphoma
por: Dang, Jun, et al.
Publicado: (2023)

Primary hepatic diffuse large B cell lymphoma: A case report: Primary hepatic diffuse large B cell lymphoma
por: Ma, Yuan-Ji, et al.
Publicado: (2011)

Systematic review of therapy used in relapsed or refractory diffuse large B-cell lymphoma and follicular lymphoma
por: Galaznik, Aaron, et al.
Publicado: (2018)

Unfavorable prognosis of nephroblastoma in adults
por: Huszno, Joanna, et al.
Publicado: (2013)

High Expression of KIF26B in Breast Cancer Associates with Poor Prognosis
por: Wang, Qun, et al.
Publicado: (2013)

KIF15 is involved in development and progression of Burkitt lymphoma
por: Wang, Zhao, et al.
Publicado: (2021)

Genomic complexity is associated with epigenetic regulator mutations and poor prognosis in diffuse large B-cell lymphoma
por: You, Hua, et al.
Publicado: (2021)

More Pronounced Muscle Loss During Immunochemotherapy is Associated with Worse Clinical Outcomes in Newly Diagnosed Patients with Diffuse Large B-Cell Lymphoma with Unfavorable Features
por: Lucijanic, Marko, et al.
Publicado: (2021)

KLHDC8A Expression in Association with Macrophage Infiltration and Oxidative Stress Predicts Unfavorable Prognosis for Glioma
por: Cheng, Tong, et al.
Publicado: (2022)

Association between BACH2 expression and clinical prognosis in diffuse large B-cell lymphoma
por: Ichikawa, Satoshi, et al.
Publicado: (2014)

Tumor-associated neutrophils correlate with poor prognosis in diffuse large B-cell lymphoma patients
por: Manfroi, B., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_399cgm1kpom03tm188rql6732v